ArabFinance: The Egyptian Stock Exchange (EGX) stated the period of stabilization fund of Rameda Pharmaceutical's (RMDA) shares will end on Jan.-12 session, according to the IPO notice.
The company added the stabilization fund lasts for 30 days starting from the first day of stock trading.
Rameda listed 49% of its shares on the Egyptian exchange in two tranches, priced at 4.66 pounds, saying it aimed to use the cash raised to expand its product range and potentially acquire other pharmaceutical companies.
Rameda, established by Gulf investors in 1994, manufactures and sells a wide range of branded generic pharmaceutical products, exporting to six countries, according to its website.
Copyright © 2019 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
